Search results
Results from the WOW.Com Content Network
Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. [1] It contains mometasone a steroid and formoterol a long-acting beta agonist. [1] It is only recommended in those for whom an inhaled steroid is not sufficient. [1] It is used by inhalation. [1]
Mometasone, also known as mometasone furoate, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever, and asthma. [10] [11] [12] Specifically it is used to prevent rather than treat asthma attacks. [10] It can be applied to the skin, inhaled, or used in the nose.
It is the first asthma triple-combination therapy; it consists of a fixed-dose combination of three active substances (indacaterol, glycopyrronium bromide and mometasone furoate) in capsules, to be administered using an inhaler. [11] An optional electronic sensor may also be co-packed with the product. [11]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.
Airedale NHS Foundation Trust, established 1 November 1991 as Airedale NHS Trust, [2] authorised as a foundation trust on 1 June 2010. [3]Alder Hey Children's NHS Foundation Trust, established 21 December 1990 as Royal Liverpool Children's Hospital and Community Services NHS Trust, [4] changed its name to The Royal Liverpool Children's National Health Service Trust on 15 March 1996, [5 ...
"Advances in inhaler therapy for asthma and chronic obstructive pulmonary disease: a comprehensive review of Fostair and Trimbow". Journal of Pharmacy and Pharmacology . doi : 10.1093/jpp/rgae090 .
It became a Foundation Trust in 2004. A merger with Southend University Hospital NHS Foundation Trust and Mid Essex Hospital Services NHS Trust was proposed in January 2018. [3] On 31 July 2019 the Secretary of State for Health and Social Care endorsed the merger and a provisional date of 1 April 2020 was agreed. [4]